Video from Pharmac - Discussing the funding of lisdexamfetamine and removal of renewal criteria

11 November 2024

Following on from the media release, please see the below Youtube video received from Pharmac.

Pharmac's Chief Medical Officer, Dr David Hughes discussing the funding of lisdexamfetamine (Vyvanse) and removal of the renewal criteria for ADHD treatments.